340B 按药房所有权的合同药房增长:2009-2022年
Claire McGlave1, John P Bruno2, Elizabeth Watts1
1Division of Health Policy and Management, University of Minnesota, Minneapolis, MN 55455, United States.
Health affairs scholar
|May 17, 2024
概括
340B药品定价计划显著涉及大型零售药房连锁店,其中71%作为合同药房参与. 这些连锁店管理更多的合同,并为更远的患者提供服务,突出了他们在发放折扣门诊药物的关键作用.
科学领域:
- 卫生经济学 卫生经济学
- 药房实践 在药房实践中
- 公共卫生政策 公共卫生政策
背景情况:
- 340B药品定价计划使符合条件的医疗保健机构能够以降低价格购买门诊药物.
- 合同药房是被覆盖实体在分发这些折扣药物的必要合作伙伴.
- 了解药房参与模式对于计划完整性和患者获取至关重要.
研究的目的:
- 根据药房所有权类型,分析合同药房参与340B计划.
- 为了比较不同药房类别的合同流行,合同数量,服务距离和供应商附属关系.
主要方法:
- 药房被分为四个所有权群体:前四大连锁店,杂货连锁店,小连锁店和机构独立药房.
- 对2022年340B个合同药房数据的分析.
- 参与率,中位数合同数量,中位数最远合同距离,与安全网提供商合同比例的比较.
主要成果:
- 在2022年,4大连锁药店中有71%的药店,机构药店中有41%,杂货药店中有38%,独立药店中有22%是合同药店.
- 前四大连锁店和杂货药店的中位数为2个合同,而其他有1.
- 4大连锁店 (19英里) 和小连锁店 (18英里) 拥有最大的中位距离到覆盖实体;独立和机构药房的距离最小 (10英里).
- 在前四大连锁店中,与核心安全网提供商 (75%) 的合同比例高于机构药房 (61%).
结论:
- 大型零售药房连锁店作为合同药房,在340B计划中发挥着重要作用.
- 药房所有权显著影响340B计划中的参与水平,合同量和地理范围.
- 这些发现表明,主要连锁店在为安全网提供者提供服务和长途分发340B药物方面发挥着集中作用.
相关概念视频
01:02Prescription, Nonprescription and Orphan Drugs
721
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
721
01:20Chronopharmacokinetics: Time-Dependent Pharmacokinetics
126
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
126
01:20Pharmacokinetic Models: Overview
665
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
665
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
157
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
157
01:27Factors Influencing Drug Absorption: Drug Dissolution
468
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
468